I agree with those who have pointed out that you are probably premature in worrying about
this. But that doesn't invalidate your interest in the question.
You mention that you've found various studies comparing early and late ADT. Here is one from the 2014 ASCO meeting that discusses exactly that question:
http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/5003?sid=aaa1e972-4baa-4572-988d-d2feec5b1093This looks at the difference in survival between those who started ADT within 3 months of biochemical recurrence and those that waited (at least 2 years) until there were symptoms, metastasis or short doubling time. (The abstract does not define short.)
Their conclusion is that there was no statistical difference in prostate specific survival in the population they studied.
One rationale for delaying is that the cancer will eventually become hormone resistant and that there is little point, in terms of quality of life, in using that weapon until you need it.
But one's state of mind is maybe the most important component of quality of life and for many facing this decision knowing that they are doing everything they can may be essential to that peace of mind.
My reading of the study is that one is justified in following either approach without worrying about
how the choice will affect survival.
My own decision was to delay ADT and still is, despite having just stopped chemo early due to complications. There were many factors behind that decision, not just survival time.
(Apologies for not following my post with my numbers. I'm new here and not sure whether this is expected or required.)